Author(s): Tamilanban T, Naveen Kumar V, Narayanan J, Prathusa S, Dhivya N, Manasa K


DOI: 10.5958/0974-360X.2020.00428.X   

Address: Tamilanban T*, Naveen Kumar V, Narayanan J, Prathusa S, Dhivya N, Manasa K
Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur-603203, Chennai, Tamailnadu, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 5,     Year - 2020

Objective: In the present study, luteolin was isolated from Momordica charantia and characterized by IR and NMR spectroscopy, undergone in silico docking to study its anti-Alzheimer’s role. In silico molecular docking is a computational system employed to predict the interaction vitality between two particles and the best introduction of ligand that shapes a complex with general least vitality. Methods: In this Protein Ligand Docking, we have used HEX 8.0.0 as a Docking Software. The receptors (PDB ID: 4PQE, 1P0I, 5O3L, 1J1C, 3NYJ, 2FJZ) were retrieved from the RCSB Protein Data Bank (PDB) Database while the ligand structure was retrieved as mol format from ChEBI database and it was converted as .pdb format using Chimera 1.12 and docking was done according to the specified parameters. Results: The molecular docking process for the luteolin was performed with the receptors and the E-value was determined. Further, the result of the binding site of ligand with the target proteins was interpreted by using Chimera 1.12 software. Conclusion: Luteolin was proved to have good affinity for target protein and it is having multitarget activity that is responsible for AD.

Cite this article:
Tamilanban T, Naveen Kumar V, Narayanan J, Prathusa S, Dhivya N, Manasa K. In silico Molecular docking of Luteolin from Momordica charantia for dementia in Alzheimer’s disease. Research J. Pharm. and Tech 2020; 13(5): 2381-2386. doi: 10.5958/0974-360X.2020.00428.X

Tamilanban T, Naveen Kumar V, Narayanan J, Prathusa S, Dhivya N, Manasa K. In silico Molecular docking of Luteolin from Momordica charantia for dementia in Alzheimer’s disease. Research J. Pharm. and Tech 2020; 13(5): 2381-2386. doi: 10.5958/0974-360X.2020.00428.X   Available on:

1.    Alexander K, Robert P. Novel insights for the treatment of Alzheimer's disease. Progressive Neuropsychopharmacology in Biology and Psychiatry. 2011; 35: 373-379.
2.    Kishu Tripathi. A Review- Garlic; the Spice of life. Asian Journal of Research in Chemistry.2009; 2(1):8-13.
3.    Mann DMA. Pyramidal nerve cell loss in Alzheimer’s disease.Neurodegeneration. 1996; 5: 423–7.
4.    Reddy PB, Reddy MS. Isolation of Secondary Metabolites from Pseudomonas fluorescens and its Characterization. Asian Journal of Research in Chemistry.2009; 2: 26-29.
5. show.
6.    Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica Charantia: A Review. Journal of Ethnopharmacology.2004; 93(1): 123-132.
7.    Bown D. The Herb Society of America Encyclopedia of Herbs & Their Uses. 1st ed. Dorling Kindersley Publishing Inc, New York.1995; 135.
8.    Jeon IH, Kim HS, Kang HJ, Lee HS, Jeong SI, Kim SJ. Anti-inflammatory and antipruritic effects of luteolin from Perilla (P. frutescent L.) leaves. Molecules. 2014; 19: 6941–6951.
9.    Hao Dong, Xiaocui Yang, Jiapeng He, Sheng Cai, Kaijun Xiao, Liang Zhu. Enhanced antioxidant activity, antibacterial activity and hypoglycemic effect of luteolin by complexation with manganese (II) and its inhibition kinetics on xanthine oxidase. RSC Advances. 2017; 7: 53385.
10.    Zhang JX, Xing JG, Wang LL. Luteolin inhibits fibrillary beta-amyloid1- 40-induced inflammation in a human blood-brain barrier model by suppressing the p38 MAPK-mediated NF-kappaB signaling pathways. Molecules.2017; 22: 334.
11.    Yohan Seo, Kunhi Ryu, Jinhong Park, Dong-kyu Jeon, Sung woo Jo, Lee HK, Wan Namkung. Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3cells. PLOS ONE.2017; 3: 132-136.
12.    Rufi Tambe, Aditi Patil, Pankaj Jain, Jayant Sancheti, Gauresh Somani, Sadhana Sathaye. Assessment of luteolin isolated from Eclipta alba leaves in animal models of epilepsy. Pharmaceutical Biology.2008; 55 (1): 264-268.
13.    Sachin J, Neetesh J, Tiwari A, Balekar N, Jain D K.Simple Evaluation of Wound Healing Activity of Polyherbal Formulation of Roots of Ageratum conyzoides Linn.Asian Journal of Research in Chemistry. 2014; 3(4): 66-73.
14.    Nikhat F,.Satynarayana D, Subhramanyam EVS.Isolation, Charectrisation and Screening of Antioxidant Activity of the Roots of Syzygiumcuminii (L) Skeel. Asian Journal of Research in Chemistry.209: 2(2): 218-221.
15.    Saini R , Chaturvedi S, Bhartiya HP, Priyanka S.Ester and Fatty Acid from Pleurospermum densiflorum. Asian Journal of Research in Chemistry.2009: 2(1):32-36.
16.    Manjula B, Shivalinge Gowda KP, Syed Mansoor Ahamed, Nagarjan T, Gaurav G.Role of Omega Fatty Acids in Human Body. Asian Journal of Research in Chemistry. 2009; 2(2): 93-99.
17.    U Rakesh SU, Salunkhe VR, Dhabale PN, Burade KB.HPTLC Method for Quantitative Determination of Gallic Acid in Hydroalcoholic Extract of Dried Flowers of Nymphaea Stellata Willd. Asian Journal of Research in Chemistry.2011; 2(2): 63-67.
18.    Ode OJ, Asuzu IU. Luteolin isolated from the methanol extract identified as the single carbon compound responsible for broad antiulcer activities of Cassia sinueana leaves. IOSR Journal of Pharmacy. 2014; 4(10):17-23.
19.    Saini R, Rai AK, Kesari AN, M Shahar MY. Synthesis and Biological Evaluation of 2,5 Di-substituted 1, 3, 4 oxadiazoles. Asian Journal of Research in Chemistry. 2014; 2(7): 126-132.
20.    Karthick T, Poonam Tandon. Computational approaches to find the active binding sites of biological targets against busulfan. Journal of Molecular Modelling. 2016; 22:142.
21.    Uthaman Gowthaman,Mannu Jayakanthan, Durai Sundar. Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry. BMC Bioinformatics. 2008;9(12):1-10.
22.    Vindhya VG, Anusha Bhaskar. Charecterization of endoglin gene using insilico tools. International Journal of Pharmaceutical Sciences and Research. 2018; 8(9): 3837-3842.
23.    Kirill Degtyarenko,Paula de Matos, Marcus Ennis, Janna Hastings, Martin Zbinden,Alan McNaught. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Research. 2008; 36:344-350.
24.    Sai Harika M, Raj Kumar T, Siva Sankar Reddy L. Docking studies of benzimidazole derivatives using Hex 8.0. International Journal of Pharmaceutical Sciences and Research. 2017; 8(4): 1677-1688.
25.    Pettersen EF, Goddard TD, Huang CC, Ferrin TE. UCSF Chimera- A visualization system for exploratory research and analysis. Journal of Computational Chemistry.2000; 25(13): 1605-1612.
32.    Vishnuvarthan VJ, Lakshmi KS. In-Silico Screening of Flavonoids targeted for Death Receptors in Cancer by Using Hex Molecular Docking. Journal of Young Pharmacists. 2017; 9(2): 168-171.
33.    Lovell SC, Davis IW, Arendall WB, Bakker PIW, Word JM, Prisant MG, Richardson JS, Richardson DC. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins: Structure, Function & Genetics. 2002; 50:437-450.
34.    Anjali Singh, Shweta Kumari, Tapan Kumar Pa. In silico analysis for laccase-mediated bioremediation of the emerging pharmaceutical pollutants. International Journal of Bioautomation. 2015; 19(4) : 423-432.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available